Tesamorelin/Ipamorelin Injectable

Price

$300.00

*Results may vary for each individual and must be medically necessary. Consult your prescriber to discuss the best treatment options for you.

Tesamorelin/Ipamorelin Injectable

Strength: 1mg/0.5mg/ml – 6ml vial for one month

Pricing: $300 for one month / $550 for two months.

Directions: Inject as prescribed.

Notes: Tesamorelin dosage and instructions vary.

Understand the Science

Tesamorelin/Ipamorelin is a synergistic peptide combination designed to stimulate natural growth hormone production.

Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that signals the pituitary gland to increase HGH production, while Ipamorelin is a selective growth hormone secretagogue (GHS) that stimulates growth hormone release without significantly impacting cortisol or prolactin levels.

Together, they work to enhance physiologic growth hormone output in a balanced, controlled manner.

Originally, Tesamorelin was FDA-approved for HIV-related fat redistribution. Today, this combination therapy is increasingly used to support fat loss, metabolic function, muscle preservation, and overall vitality in aging adults.

Benefits of Tesamorelin/Ipamorelin: 

  • Stimulates natural HGH production
  • Supports reduction of abdominal and visceral fat
  • Promotes lean muscle preservation and body composition improvements
  • Supports metabolic health and recovery
  • May enhance energy, sleep quality, and overall wellness
  • Utilized in clinical settings with ongoing research support

Common Side effects

  • Injection site irritation

  • Mild water retention

  • Headache

  • Flushing

  • Temporary changes in appetite

 

Strength: 1mg/0.5mg/ml — 6ml vial (1-month supply)

Application: Inject as prescribed by your healthcare provider [How to Inject]

Dosing: Adjusted to individual medical needs

Monitoring: Prescriber consultation required; must be medically appropriate

Tesamorelin/Ipamorelin is a highly targeted therapy, particularly effective for patients with fat redistribution concerns or metabolic health goals.